UNITED THERAPEUTICS Corp
UTHRNasdaqCIK 1082554HealthcareFiscal year ends Dec 31
Reports and events: 324 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2207:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117964 |
| 2026-10-1407:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115723 |
| 2026-09-0817:12 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-105953 |
| 2026-08-0506:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-26-000028 |
| 2026-08-0506:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001082554-26-000027 |
| 2026-07-2307:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-086068 |
| 2026-06-2916:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-078865 |
| 2026-05-0606:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-26-000021 |
| 2026-05-0606:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001082554-26-000020 |
| 2026-04-2906:33 ET | DEF 14A | Proxy statementPeriod 2026-06-26 | 0001082554-26-000009 |
| 2026-03-3007:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-036445 |
| 2026-03-0917:18 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-025331 |
| 2026-03-0206:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-021869 |
| 2026-02-2506:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-26-000007 |
| 2026-02-2506:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001082554-26-000006 |
| 2026-01-2216:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-005810 |
| 2025-10-2906:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-25-000036 |
| 2025-10-2906:32 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001082554-25-000034 |
| 2025-09-0207:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-085976 |
| 2025-08-0117:17 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-073163 |
| 2025-07-3006:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-036543 |
| 2025-07-3006:34 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-036541 |
| 2025-06-2707:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-063287 |
| 2025-04-3006:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-25-000024 |
| 2025-04-3006:32 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001082554-25-000023 |
| 2025-04-2906:31 ET | DEF 14A | Proxy statementPeriod 2025-06-26 | 0001082554-25-000014 |
| 2025-04-2806:31 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-039710 |
| 2025-02-2606:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-25-000007 |
| 2025-02-2606:33 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001082554-25-000005 |
| 2025-01-1308:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002892 |
| 2024-10-3006:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-24-000049 |
| 2024-10-3006:32 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001082554-24-000047 |
| 2024-07-3106:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-24-000037 |
| 2024-07-3106:31 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001082554-24-000035 |
| 2024-06-2707:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-075375 |
| 2024-05-0106:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-24-000027 |
| 2024-05-0106:32 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001082554-24-000025 |
| 2024-04-2907:00 ET | DEF 14A | Proxy statementPeriod 2024-06-26 | 0001082554-24-000017 |
| 2024-03-2916:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-24-041160 |
| 2024-03-2516:56 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-038478 |
| 2024-02-2706:03 ET | 8-K | 8.01 Other events | 0001104659-24-027791 |
| 2024-02-2106:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001082554-24-000007 |
| 2024-02-2106:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001082554-24-000005 |
| 2023-12-2209:51 ET | SC 13D | Ownership report, active investor | 0001104659-23-128620 |
| 2023-12-2017:00 ET | 8-K | 8.01 Other events | 0001104659-23-127766 |
| 2023-11-2906:00 ET | 8-K | 8.01 Other events | 0001104659-23-121738 |
| 2023-11-0106:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-23-000033 |
| 2023-11-0106:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001082554-23-000031 |
| 2023-08-0206:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-23-000024 |
| 2023-08-0206:02 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001082554-23-000022 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:40 ET. Listed shows no prices and gives no investment advice.